ESR1 and cancer: Estrogenic compounds have been shown to modulate VEGF transcription and secretion via ERα and ERβ in both a positive and negative direction in various cancer cell lines [72]–[74], as well as in mesenchymal stem cells and murine embryonic lung cells [75], [76].